Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Thomas, Heike ^a   Jäger, Marcus ^a   Mauel, Katharina ^a   Brandau, Sven ^a   Lask, Sara ^a   Flohé, Stefanie B ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 18; STAT4 PROTEIN; IFNG PROTEIN, HUMAN; IL12B PROTEIN, HUMAN; INTERLEUKIN 12P40; STAT4 PROTEIN, HUMAN;

ARTICLE; CELL INTERACTION; COCULTURE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REGENERATION; CELL COMMUNICATION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; REGENERATION; SECRETION (PROCESS);

CELL COMMUNICATION; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-18; KILLER CELLS, NATURAL; MESENCHYMAL STROMAL CELLS; REGENERATION; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR;

EID: 84900993159     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/143463     Document Type: Article

References (35)

1. Barry F. P., Biology and clinical applications of mesenchymal stem cells. Birth Defects Research C: Embryo Today 2003 69 3 250 256 2-s2.0-0141890186 10.1002/bdrc.10021
2. Brandstadter J. D., Yang Y., Natural killer cell responses to viral infection. Journal of Innate Immunity 2011 3 3 274 279 2-s2.0-79955091252 10.1159/000324176
3. Cooper M. A., Fehniger T. A., Ponnappan A., Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. European Journal of Immunology 2001 31 792 801
4. Fehniger T. A., Shah M. H., Turner M. J., VanDeusen J. B., Whitman S. P., Cooper M. A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M. A., Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Journal of Immunology 1999 162 8 4511 4520 2-s2.0-0033561762
5. Wang K. S., Frank D. A., Ritz J., Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 2000 95 10 3183 3190 2-s2.0-0034657259
6. Presky D. H., Yang H., Minetti L. J., Chua A. O., Nabavi N., Wu C.-Y., Gately M. K., Gubler U., A functional interleukin 12 receptor complex is composed of two β -type cytokine receptor subunits. Proceedings of the National Academy of Sciences of the United States of America 1996 93 24 14002 14007 2-s2.0-0030445948
7. Nakahira M., Ahn H.-J., Park W.-R., Gao P., Tomura M., Park C.-S., Hamaoka T., Ohta T., Kurimoto M., Fujiwara H., Synergy of IL-12 and IL-18 for IFN- γ gene expression: IL-12-induced STAT4 contributes to IFN- γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. Journal of Immunology 2002 168 3 1146 1153 2-s2.0-0036467440
8. Akira S., The role of IL-18 in innate immunity. Current Opinion in Immunology 2000 12 59 63
9. Yu J., Wei M., Becknell B., Trotta R., Liu S., Boyd Z., Jaung M. S., Blaser B. W., Sun J., Benson D. M. Jr., Mao H., Yokohama A., Bhatt D., Shen L., Davuluri R., Weinstein M., Marcucci G., Caligiuri M. A., Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006 24 5 575 590 2-s2.0-33646563695 10.1016/j.immuni.2006.03.016
10. Kaplan M. H., Sun Y.-L., Hoey T., Grusby M. J., Impaired IL-12 responses and enhanced development of Th2 cells in Stat4- deficient mice. Nature 1996 382 6587 174 177 2-s2.0-0029937270 10.1038/382174a0
11. Degli-Esposti M. A., Smyth M. J., Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nature Reviews Immunology 2005 5 2 112 124 2-s2.0-13444311714 10.1038/nri1549
12. Walzer T., Dalod M., Robbins S. H., Zitvogel L., Vivier E., Natural-killer cells and dendritic cells: 'L'union fait la force'. Blood 2005 106 7 2252 2258 2-s2.0-26844581032 10.1182/blood-2005-03-1154
13. Cheng M., Nguyen M.-H., Fantuzzi G., Koh T. J., Endogenous interferon- γ is required for efficient skeletal muscle regeneration. The American Journal of Physiology-Cell Physiology 2008 294 5 C1183 C1191 2-s2.0-48249099757 10.1152/ajpcell.00568.2007
14. Duque G., Huang D. C., Dion N., MacOritto M., Rivas D., Li W., Yang X. F., Li J., Lian J., Marino F. T., Barralet J., Lascau V., Deschênes C., Ste-Marie L.-G., Kremer R., Interferon-Î plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. Journal of Bone and Mineral Research 2011 26 7 1472 1483 2-s2.0-79959491400 10.1002/jbmr.350
15. Liu Y., Wang L., Kikuiri T., Akiyama K., Chen C., Xu X., Yang R., Chen W., Wang S., Shi S., Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN- γ and TNF- Nature Medicine 2011 17 12 1594 1601 2-s2.0-84855517156 10.1038/nm.2542
16. Jewett A., Man Y. G., Tseng H. C., Dual functions of natural killer cells in selection and differentiation of stem cells, role in regulation of inflammation and regeneration of tissues. Journal of Cancer 2013 4 12 24
17. Kim N., Im K. I., Lim J. Y., Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. Annals of Hematology 2013 92 1295 1308
18. le Blanc K., Ringdén O., Immunomodulation by mesenchymal stem cells and clinical experience. Journal of Internal Medicine 2007 262 5 509 525 2-s2.0-35448996504 10.1111/j.1365-2796.2007.01844.x
19. Abumaree M., Al Jumah M., Pace R. A., Kalionis B., Immunosuppressive properties of mesenchymal stem cells. Stem Cell Reviews 2012 8 375 392 2-s2.0-80052181389 10.1007/s12015-011-9312-0
20. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 4 1815 1822 2-s2.0-13544249606 10.1182/blood-2004-04-1559
21. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., Annunziato F., Role for interferon- γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006 24 2 386 398 2-s2.0-33746889097 10.1634/stemcells.2005-0008
22. Spaggiari G. M., Capobianco A., Becchetti S., Mingari M. C., Moretta L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006 107 4 1484 1490 2-s2.0-32644438233 10.1182/blood-2005-07-2775
23. Poggi A., Prevosto C., Massaro A.-M., Negrini S., Urbani S., Pierri I., Saccardi R., Gobbi M., Zocchi M. R., Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. Journal of Immunology 2005 175 10 6352 6360 2-s2.0-27744541175
24. DelaRosa O., Sanchez-Correa B., Morgado S., Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells and Development 2012 21 1333 1343
25. Spaggiari G. M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M. C., Moretta L., Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008 111 3 1327 1333 2-s2.0-38949183675 10.1182/blood-2007-02-074997
26. Pastille E., Didovic S., Brauckmann D., Rani M., Agrawal H., Schade F. U., Zhang Y., Flohé S. B., Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. Journal of Immunology 2011 186 2 977 986 2-s2.0-79251552541 10.4049/jimmunol.1001147
27. Kang H. S., Habib M., Chan J., Abavana C., Potian J. A., Ponzio N. M., Rameshwar P., A paradoxical role for IFN- γ in the immune properties of mesenchymal stem cells during viral challenge. Experimental Hematology 2005 33 7 796 803 2-s2.0-20444458975 10.1016/j.exphem.2005.03.012
28. Caligiuri M. A., Human natural killer cells. Blood 2008 112 3 461 469 2-s2.0-50949124847 10.1182/blood-2007-09-077438
29. Szabo S. J., Kim S. T., Costa G. L., Zhang X., Fathman C. G., Glimcher L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000 100 6 655 669 2-s2.0-0034677646
30. Szabo S. J., Sullivan B. M., Sternmann C., Satoskar A. R., Sleckman B. P., Glimcher L. H., Distinct effects of T-bet in Th1 lineage commitment and IFN- γ production in CD4 and CD8 T cells. Science 2002 295 5553 338 342 2-s2.0-0037059462 10.1126/science.1065543
31. Afkarian M., Sedy J. R., Yang J., Jacobson N. G., Cereb N., Yang S. Y., Murphy T. L., Murphy K. M., T-bet is a STATI-induced regulator for IL-12R expression in naïve CD4+ T cells. Nature Immunology 2002 3 6 549 557 2-s2.0-0035997908 10.1038/ni794
32. Thierfelder W. E., van Deursen J. M., Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T., Sangster M. Y., Vignali D. A. A., Doherty P. C., Grosveld G. C., Ihle J. N., Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996 382 6587 171 174 2-s2.0-15844396183 10.1038/382171a0
33. Meisel R., Brockers S., Heseler K., Degistirici O., Bülle H., Woite C., Stuhlsatz S., Schwippert W., Jäger M., Sorg R., Henschler R., Seissler J., Dilloo D., Däubener W., Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011 25 4 648 654 2-s2.0-79958295717
34. Duque G., Huang D. C., Macoritto M., Rivas D., Yang X. F., Ste-Marie L. G., Kremer R., Autocrine regulation of interferon γ in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009 27 3 550 558 2-s2.0-65249093158 10.1634/stemcells.2008-0886
35. Jasmin, Jelicks L. A., Koba W., Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go? PLoS Neglected Tropical Diseases 1971 6 e1971 10.1371/journal.pntd.0001971